Paraventricular thalamic nucleus nerve pathways involved in general anesthesia wakefulness and sleep wakefulness

doi:10.12092/j.issn.1009-2501.2023.12.015

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2023, Vol. 28 ›› Issue (12): 1436-1440.doi: 10.12092/j.issn.1009-2501.2023.12.015

Previous Articles Next Articles

Paraventricular thalamic nucleus nerve pathways involved in general anesthesia wakefulness and sleep wakefulness

GU Yunfei1, CHEN Suheng1, YU Kaihua1, BAO Zhenxing1, LI Yulan2

1The First Clinical Medical College of Lanzhou University, Lanzhou 730000, Gansu, China; 2Department of Anesthesiology, First Hospital of Lanzhou University, Lanzhou 730000, Gansu, China

Received:2023-07-10 Revised:2023-08-25 Online:2023-12-26 Published:2023-12-21

Abstract

Abstract:

The paraventricular thalamic nucleus (PVT) is a key nucleus involved in wakefulness. PVT plays an important role in normal sleep-wake regulation, but its role may vary during anesthesia depending on the stage of anesthesia. This article will review the role of PVT in sleep and anesthesia based on its wakefulness function neural pathways.

Key words: paraventricular thalamic nucleus, general anesthesia, sleep, wakefulness, consciousness

CLC Number:

R96
R614

GU Yunfei, CHEN Suheng, YU Kaihua, BAO Zhenxing, LI Yulan. Paraventricular thalamic nucleus nerve pathways involved in general anesthesia wakefulness and sleep wakefulness[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(12): 1436-1440.

[1]	XU Jinhui, YUE Hongmei, LI Yating, LIU Miaomiao, WU Xingdong, ZHU Haobin. Advances in the study of mesenchymal stem cells in obstructive sleep apnea hypoventilation syndrome [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(1): 114-120.
[2]	WANG Juan, LIU Weiying, YE Yucai, FU Wenli, ZHANG Sha, LI Leping. Research progress of norepinephrine reuptake inhibitor combined with antimuscarinic in the treatment of obstructive sleep apnea [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(6): 714-720.
[3]	ZHU Haobin, YUE Hongmei, WU Xingdong, LIU Miaomiao, LI Yating, XU Jinhui. Research progress on the role of the Nrf2 signaling pathway in the complications associated with obstructive sleep apnea [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(11): 1283-1291.
[4]	YANG Jie, CAO Junli, LIU He. Research progress on the effect of noninvasive neuromodulation technique on patients with postoperative sleep disturbances after general anesthesia [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(12): 1322-1332.
[5]	YAN Lei, JIANG Haibin, NAFEISHA Paerhati, REZIWANGULI Yikemu, GENG Boyu, MAIERHABA Maimaitiaili. Effects of different doses of dexmedetomidine on non-cardiac surgery stress and postoperative sleep in patients with coronary heart disease [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(12): 1340-1346.
[6]	NI Yuanbo, ZHANG Xin, LI Yi, LIU Cunming. Anesthetics, analgesics and cognitive function [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(12): 1365-1374.
[7]	DING Jiahui, ZHOU Yu, YUAN Tianjie, XIA Junming, LI Wenxian, HAN Yuan. Research progress of anesthesia-related neural network in depth of anesthesia monitoring [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(12): 1400-1407.
[8]	JIANG Jianbo, SUN Qian, DING Fengfei. Interstitial ions regulate sleep and wakefulness [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(7): 794-801.
[9]	WANG Mengmeng, ZHAO Zhongxin, WU Huijuan. Progresses in clinical manifestations and treatments of narcolepsy [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(5): 491-496.
[10]	YUAN Yuan, ZHANG Yimeng, LI Ning, ZHAN Shuqin. Progress in the diagnosis and treatment of rapid eye movement sleep behavior disorder [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(5): 504-510.
[11]	WU Wei, DENG Liying. Strategies for the treatment of circadian dysrhythmic sleep and wakefulness disorder [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(5): 511-515.
[12]	HUANG Yaqin, XUE Rong. Treatment of sleep disorder in patients with acute cerebrovascular disease [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(5): 516-521.
[13]	JIN Baowei, JIANG Zongming, GUO Jianrong. Clinical application and research progress of remimazolam [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(12): 1444-1448.
[14]	LI Jiayi, ZHANG Yimeng, WANG Chenxi, LI Jun, PAN Yan. Relationship between circadian rhythm sleep-wake disorders and the development of malignant tumor [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(1): 76-81.
[15]	SUN Xiao, YANG Surong, LI Shanqun, WANG Yiqun. Regulation of REM sleep: Basic mechanisms and clinical drugs [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(2): 214-220.

Paraventricular thalamic nucleus nerve pathways involved in general anesthesia wakefulness and sleep wakefulness

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments